Shyam Prabhakaran
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shyam Prabhakaran has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Eric D. Peterson
¶ Duke Clinical Research Institute, Durham, North Carolina; and Massachusetts General Hospital, Boston, Massachusetts
1 shared publication- Eric Edward Smith
Department of Clinical Neurosciences, University of Calgary, Canada
1 shared publication - Gregg Fonarow
Ahmanson-UCLA Cardiomyopathy Center, Division of Cardiology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA
1 shared publication Ji Y. Chong
1 shared publication- Lee H. Schwamm
Department of Neurology, Yale School of Medicine, New Haven, CT (L.H.S.).
1 shared publication Li Liang
¶ Duke Clinical Research Institute, Durham, North Carolina; and Massachusetts General Hospital, Boston, Massachusetts
1 shared publication
Latest Publications
- 1 November 2014
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 75 (5) , 500-508
Hospital Case Volume Is Associated With Mortality in Patients Hospitalized With Subarachnoid Hemorrhage
BACKGROUND:. Prior studies have suggested that hospital case volume may be associated with improved outcomes after subarachnoid hemorrhage (SAH), but co
- 1 November 2014
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 75 (5) , 500-508
Hospital Case Volume Is Associated With Mortality in Patients Hospitalized With Subarachnoid Hemorrhage
BACKGROUND:. Prior studies have suggested that hospital case volume may be associated with improved outcomes after subarachnoid hemorrhage (SAH), but co
- 1 April 2014
- Published by Wolters Kluwer Health in Continuum
- Vol. 20 (2) , 296-308
Risk Factor Management for Stroke Prevention
This review focuses on the recommendations for management of hypertension, dyslipidemia, diabetes mellitus, diet, physical activity, and lifestyle choices commonly encountered in neurologic practice. Specific studies, including those relevant to lipid targets, blood pressure targets, and adherence to medications after stroke, are reviewed. In addition to traditional risk factors such as hypertension, dyslipidemia, and diabetes mellitus, this review discusses sleep apnea, diet, physical activity, and other novel risk factors that are potentially modifiable. Recent studies confirm that pharmacologic strategies to achieve aggressive targets for lipid and blood pressure lowering have significant impact on recurrent stroke risk. Optimal secondary prevention strategies can prevent as much as 80% of all recurrent strokes.
- 1 April 2014
- Published by Wolters Kluwer Health in Continuum
- Vol. 20 (2) , 296-308
Risk Factor Management for Stroke Prevention
This review focuses on the recommendations for management of hypertension, dyslipidemia, diabetes mellitus, diet, physical activity, and lifestyle choices commonly encountered in neurologic practice. Specific studies, including those relevant to lipid targets, blood pressure targets, and adherence to medications after stroke, are reviewed. In addition to traditional risk factors such as hypertension, dyslipidemia, and diabetes mellitus, this review discusses sleep apnea, diet, physical activity, and other novel risk factors that are potentially modifiable. Recent studies confirm that pharmacologic strategies to achieve aggressive targets for lipid and blood pressure lowering have significant impact on recurrent stroke risk. Optimal secondary prevention strategies can prevent as much as 80% of all recurrent strokes.